J.W. Cole Advisors Inc. increased its stake in shares of Danaher Co. (NYSE:DHR – Get Rating) by 31.1% during the 1st quarter, Holdings Channel.com reports. The fund owned 2,132 shares of the conglomerate’s stock after purchasing an additional 506 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Danaher were worth $625,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. GHP Investment Advisors Inc. acquired a new position in Danaher in the first quarter valued at $26,000. Lloyd Advisory Services LLC. acquired a new position in Danaher in the first quarter valued at $26,000. Landmark Wealth Management LLC acquired a new position in Danaher in the first quarter valued at $32,000. Lansing Street Advisors acquired a new position in Danaher in the first quarter valued at $34,000. Finally, American National Bank acquired a new position in Danaher in the first quarter valued at $35,000. 77.27% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Danaher
In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of the company’s stock in a transaction dated Monday, July 25th. The shares were sold at an average price of $271.13, for a total value of $3,253,560.00. Following the sale, the executive vice president now owns 74,398 shares of the company’s stock, valued at $20,171,529.74. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Rainer Blair sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the transaction, the chief executive officer now owns 79,739 shares of the company’s stock, valued at $23,921,700. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The disclosure for this sale can be found here. Insiders have sold 40,906 shares of company stock valued at $11,823,179 over the last quarter. Corporate insiders own 11.20% of the company’s stock.
Danaher Stock Down 1.7 %
Danaher (NYSE:DHR – Get Rating) last announced its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.35 by $0.41. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The company had revenue of $7.75 billion for the quarter, compared to the consensus estimate of $7.29 billion. During the same quarter in the prior year, the firm earned $2.46 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, research analysts expect that Danaher Co. will post 10.4 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.36%. The ex-dividend date of this dividend is Thursday, September 29th. Danaher’s dividend payout ratio (DPR) is presently 11.78%.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Credit Suisse Group assumed coverage on shares of Danaher in a report on Wednesday, August 24th. They issued an “outperform” rating and a $340.00 target price on the stock. UBS Group lifted their target price on shares of Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a report on Thursday, July 28th. Robert W. Baird lifted their target price on shares of Danaher from $319.00 to $325.00 in a report on Friday, July 22nd. StockNews.com raised shares of Danaher from a “buy” rating to a “strong-buy” rating in a report on Friday, August 26th. Finally, Barclays lifted their target price on shares of Danaher from $290.00 to $310.00 in a report on Friday, July 22nd. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $321.45.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.